گیرنده ۳ بی سروتونین
برای مطالعهٔ بیشتر

Need AC, Keefe RS, Ge D,  et al. (2009). "Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis". Eur. J. Hum. Genet. 17 (7): 946–957. doi:10.1038/ejhg.2008.264. PMC 2986499. PMID 19156168.
Meineke C, Tzvetkov MV, Bokelmann K,  et al. (2008). "Functional characterization of a -100_-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B gene". Pharmacogenet. Genomics. 18 (3): 219–230. doi:10.1097/FPC.0b013e3282f51092. PMID 18300944. S2CID 44722598.
Levran O, Londono D, O'Hara K,  et al. (2008). "Genetic susceptibility to heroin addiction; a candidate-gene association study". Genes, Brain and Behavior. 7 (7): 720–729. doi:10.1111/j.1601-183X.2008.00410.x. PMC 2885890. PMID 18518925.
Kato M, Fukuda T, Wakeno M,  et al. (2006). "Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients". Neuropsychobiology. 53 (4): 186–195. doi:10.1159/000094727. PMID 16874005. S2CID 25730662.
Hu XQ, Peoples RW (2008). "The 5-HT3B subunit confers spontaneous channel opening and altered ligand properties of the 5-HT3 receptor". J. Biol. Chem. 283 (11): 6826–6831. doi:10.1074/jbc.M707571200. PMID 18187416.
Krzywkowski K, Davies PA, Feinberg-Zadek PL,  et al. (2008). "High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor". Proc. Natl. Acad. Sci. U.S.A. 105 (2): 722–727. doi:10.1073/pnas.0708454105. PMC 2206603. PMID 18184810.
Ji X, Takahashi N, Branko A,  et al. (2008). "An association between serotonin receptor 3B gene (HTR3B) and treatment-resistant schizophrenia (TRS) in a Japanese population". Nagoya Journal of Medical Science. 70 (1–2): 11–17. PMID 18807291.
Kato M, Serretti A (2008). "Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder". Mol. Psychiatry. 15 (5): 473–500. doi:10.1038/mp.2008.116. PMID 18982004.
Walstab J, Hammer C, Bönisch H,  et al. (2008). "Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptors". Pharmacogenet. Genomics. 18 (9): 793–802. doi:10.1097/FPC.0b013e3283050117. PMID 18698232. S2CID 61196.
Yosifova A, Mushiroda T, Stoianov D,  et al. (2009). "Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population". Journal of Affective Disorders. 117 (1–2): 87–97. doi:10.1016/j.jad.2008.12.021. PMID 19328558.
Tzvetkov MV, Meineke C, Oetjen E,  et al. (2007). "Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine". Gene. 386 (1–2): 52–62. doi:10.1016/j.gene.2006.08.002. PMID 17010535.
Oades RD, Lasky-Su J, Christiansen H,  et al. (2008). "The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis". Behavioral and Brain Functions. 4: 48. doi:10.1186/1744-9081-4-48. PMC 2577091. PMID 18937842.
Fasching PA, Kollmannsberger B, Strissel PL,  et al. (2008). "Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy". J. Cancer Res. Clin. Oncol. 134 (10): 1079–1086. doi:10.1007/s00432-008-0387-1. PMID 18389280. S2CID 7504731.
Tanaka M, Kobayashi D, Murakami Y,  et al. (2008). "Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea". Int. J. Neuropsychopharmacol. 11 (2): 261–267. doi:10.1017/S1461145707007985. PMID 17697394.
Gratacòs M, Costas J, de Cid R,  et al. (2009). "Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment". Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B (6): 808–816. doi:10.1002/ajmg.b.30902. PMID 19086053. S2CID 44524739.
Krzywkowski K, Davies PA, Irving AJ,  et al. (2008). "Characterization of the effects of four HTR3B polymorphisms on human 5-HT3AB receptor expression and signalling". Pharmacogenet. Genomics. 18 (12): 1027–1040. doi:10.1097/FPC.0b013e328310f950. PMID 19008750. S2CID 6026971.
Smith AK, Dimulescu I, Falkenberg VR,  et al. (2008). "Genetic evaluation of the serotonergic system in chronic fatigue syndrome". Psychoneuroendocrinology. 33 (2): 188–197. doi:10.1016/j.psyneuen.2007.11.001. PMID 18079067. S2CID 34029937.
de Krom M, Staal WG, Ophoff RA,  et al. (2009). "A common variant in DRD3 receptor is associated with autism spectrum disorder". Biol. Psychiatry. 65 (7): 625–630. doi:10.1016/j.biopsych.2008.09.035. PMID 19058789. S2CID 11545813.
Ducci F, Enoch MA, Yuan Q,  et al. (2009). "HTR3B is associated with alcoholism with antisocial behavior and alpha EEG power—an intermediate phenotype for alcoholism and co-morbid behaviors". Alcohol. 43 (1): 73–84. doi:10.1016/j.alcohol.2008.09.005. PMC 2754808. PMID 19185213.